Differences in cell wall thickness between resistant and nonresistant strains of Mycobacterium tuberculosis: Using transmission electron microscopy

Chemotherapy

Volumn 55, Issue 5, 2009, Pages 303-307

  Velayati, Ali Akbar ^a   Farnia, Parissa ^a,c   Ibrahim, Tengku Azmi ^c   Haroun, Rafiuz Zaman ^c   Kuan, Ho Oi ^a   Ghanavi, Jalaledin ^b   Farnia, Poopak ^b   Kabarei, Ali Naghee ^a   Tabarsi, Payam ^a   Omar, Abdul Rahman ^c   Varahram, Mohammad ^a   Masjedi, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY   (Iran)

^c UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Cell wall; TEM; Tuberculosis

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CIPROFLOXACIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; PEPTIDOGLYCAN; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CELL WALL; DISEASE PREDISPOSITION; HUMAN; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT DURATION; TUBERCULOSIS; X RAY DIFFRACTION;

CELL WALL; DRUG RESISTANCE, BACTERIAL; MICROSCOPY, ELECTRON, TRANSMISSION; MYCOBACTERIUM TUBERCULOSIS;

EID: 67649231146     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000226425     Document Type: Article

References (29)

1. World Health Organization: Global tuberculosis control - surveillance, planning, financing: WHO Report 2008. Geneva, World Health Organization, 2008. Document WHO/HTM/TB/2008.393.
2. Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, Watt CJ, Williams BG, Dye C: Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006;194:479-485.
3. Centers for Disease Control and Prevention (CDC): Emergence of Mycobacterium tuberculosis with extensive resistance to secondline drugs - worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006;55:301-305.
4. Masjedi MR, Farnia P, Sorooch S, Masjedi MR, Farnia P, Sorooch S, Pooramiri MV, Mansoori SD, Zarifi AZ, Velayatei AA: Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran. Clin Infect Dis 2006;43:841-847. (Pubitemid 44435510)
5. Farnia P, Masjedi MR, Varahram M, Mirsaeidi M, Ahmadi M, Khazampour M, Tabarsi P, Baghei P, Marjane M, Bahadori M, Zarifi AZ, Velayati AA: The recent-transmission of Mycobacterium tuberculosis strains among Iranian and Afghan relapse cases: a DNA-fingerprinting using RFLP and spoligotyping. BMC Infect Dis 2008;8:109-116.
6. Gillespie SH: Evolution of drug resistance in M. tuberculosis: clinical and molecular perspective. Antimicrob Agents Chemother 2002;46:267-274.
7. Huang Q, Chen ZF, Li YY, Zhang Y, Ren Y, Fu Z, Xu SQ: Nutrient-starved incubation conditions enhance pyrazinamide activity against M. tuberculosis. Chemotherapy 2007;53:338-343.
8. Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, Matter L, Schopfer K, Bodmer T: Detection of rifampicin-resistance mutations in M. tuberculosis. Lancet 1993;341:647-650.
9. Escribano I, Rodríguez JC, Llorca B, García-Pachon E, Ruiz M, Royo G: Importance of the efflux pump systems in the resistance of M. tuberculosis to fluoroquinolones and linezolid. Chemotherapy 2007;53:397-401.
10. Ramaswamy S, Musser JM: Molecular genetic basis of antimicrobial agent resistance in M. tuberculosis. Tuber Lung Dis 1998;79:3-29.
11. Hoffmann C, Leis A, Niederweis M, Plitzko M, Engelhardt H: Disclosure of the mycobacterial outer membrane: cryo-electron tomography and vitreous sections reveal the lipid bilayer structure. Proc Natl Acad Sci USA 2008;105:3963-3967. (Pubitemid 351723507)
12. Watanabe M, Aoyagi Y, Ridell M, Minnikin DE: Separation and characterization of individual mycolic acids in representative mycobacteria. Microbiology 2001;147:1825-1837. (Pubitemid 32684925)
13. Alsteens D, Verbelen C, Dague E, Raze D, Baulard AR, Dufrene YF: Organization of the mycobacterial cell wall: a nanoscale view. Pflügers Arch Eur J Physiol 2008;456:117-125.
14. Kent PT, Kubica GP: Public Health Mycobacteriology: A Guide for a Level III Laboratory. Atlanta, Public Health Services, 1985.
15. World Health Organization (WHO): Guidelines for drug susceptibility testing for second line anti-tuberculosis drugs for DOTs-plus. Geneva, World Health Organization, 2001, Document WHO/CDC/TB/2001.288.
16. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Hermans P, Martin C, McAdam R, Shinnick TM: Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:2406-2409.
17. Frothingham R, Meeker-O'Connell WA: Genetic diversity in the Mycobacterium tuberculosis complex based on variable numbers of tandem DNA repeats. Microbiology 1998;144:1189-1196.
18. Toda T, Takeya K, Koike M, Mori R: Electron microscopy of ultrathin sections of Mycobacterium. Fine structure of the cells grown in-vitro and in-vivo. Proc Jpn Acad 1960;36:372-375.
19. Brennan PJ: Structure of mycobacteria: recent developments in defining cell wall carbohydrates and proteins. Rev Infect Dis 1989;11:420-430.
20. Wang L, Slayden RA, Barry CE, Liu J: Cell wall structure of a mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids. J Biol Chem 2000;275:7224-7229.
21. Liu J, Barry CE, Nikaido H: In Mycobacteria; in Ratledge C, Dale JW (eds): Mycobacteria: Molecular Biology and Virulence. Oxford, Blackwell Science, 1999, pp 220-239,
22. Watanabe M, Aoyagi Y, Mitome H, Fujita T, Naoki H, Ridell M, Minnikin DE: Location of functional groups in mycobacterial meromycolate chains; the recognition of new structural principles in mycolic acids. Microbiology 2002;148:1881-1902. (Pubitemid 34679042)
23. Marcel N, Nahta A, Balganesh M: Evaluation of killing kinetics of anti-TB drugs on MTB using a bacteriophage-based assay. Chemotherapy 2008;54:404-411.
24. Cremades R, Santos A, Rodríguez JC, García-Pachón E, Ruiz M, Escribano I, Royo G: Screening for sterilizing activity of antibiotic combinations in an acid model of rapidly growing mycobacteria during the stationary phase of growth. Chemotherapy 2009;55:114-118.
25. Chopra P, Meena LS, Singh Y: New drug targets for Mycobacterium tuberculosis. Indian J Med Res 2003;117:1-9.
26. Alderwick LJ, Birch HL, Mishra AK, Eggeling L, Besra GS: Structure, function and biosynthesis of the Mycobacterium tuberculosis cell wall: arabinogalactan and lipoarabinomannan assembly with a view to discovering new drug targets. Transactions 2007;55:1325-1328.
27. Mitchison DA: The action of antituberculosis drugs in short-course chemotherapy. Tubercle 1985;66:219-225. (Pubitemid 16150082)
28. Dye C, Espinal MA: Will tuberculosis become resistant to all antibiotics? Proc R Soc Lond B Biol Sci 2000;267:1-9.
29. Raviglione MC, Smith IM: XDR tuberculosis - implication for global public health. N Engl J Med 2007;356:656-658.